Sanofi SA 4Q 2013 -- Forecast

FRANKFURT--The following is a summary of analysts' forecasts for Sanofi SA (SNY) fourth-quarter results, based on a poll of 11 analysts conducted by Dow Jones Newswires (figures in million euros, EPS, dividend and target price in euro, according to IFRS). Earnings figures are scheduled to be released February 6.

=== 
                    Net      Business    Business  Business 
4th Quarter       sales  Oper. Income  net income       EPS 
 
AVERAGE           8,470         2,509       1,816      1.36 
Prev. Year        8,526         2,118       1,550      1.17 
+/- in %           -0.7           +18         +17       +17 
 
MEDIAN            8,438         2,501       1,807      1.37 
Maximum           8,745         2,711       1,925      1.46 
Minimum           8,338         2,410       1,765      1.31 
Amount (a)           11            11           9        11 
 
Banca Sabadell    8,554         2,532       1,807      1.37 
Bernstein         8,338         2,501       1,805      1.37 
Deutsche Bank     8,405         2,518       1,811      1.37 
Exane BNP Paribas 8,745         2,503       1,796      1.36 
Helvea            8,466         2,500       1,781      1.35 
Kepler Cheuvreux  8,379         2,455          --      1.31 
Morgan Stanley    8,632         2,454       1,765      1.33 
UBS               8,438         2,475       1,814      1.37 
 
 
             Target price  Rating                  DPS 2013 
 
AVERAGE             83.07  positive 6    AVERAGE       2.80 
Prev. Quarter       86.00  neutral  3    Prev. Year    2.77 
+/- in %             -3.4  negative 1    +/- in %      +1.1 
 
MEDIAN              84.60                MEDIAN        2.80 
Maximum             90.00                Maximum       2.85 
Minimum             75.00                Minimum       2.76 
Amount                  9                Amount           6 
 
Banca Sabadell      84.60  Sell                        2.77 
Berenberg           86.00  Buy                         2.76 
Citigroup           76.00  Neutral                     2.80 
Credit Suisse       85.00  Neutral                     2.80 
Deutsche Bank       87.00  Buy                         2.83 
Exane BNP Paribas   83.00  Outperform                  0.00 
Helvea              81.00  Buy                           -- 
Kepler Cheuvreux    90.00  Buy                         2.85 
Morgan Stanley         --  Overweight                    -- 
UBS                 75.00  Neutral                       -- 
=== 

Year-earlier figures are as restated by the company.

(a) Including anonymous estimates from three more analysts.

DJG/err 

Subscribe to WSJ: http://online.wsj.com?mod=djnwires